• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 277/10 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Patent holdings for IPC class C07D 277/10

Total number of patents in this class: 51

10-year publication summary

1
3
1
3
0
0
2
2
4
2
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
University of Florida Research Foundation, Inc.
4020
8
BASF SE
20933
4
The Board of Trustees of the University of Illinois
2688
3
Kyoto University
2800
3
Glaxo Group Limited
4071
2
Jawaharlal Nehru Centre for Advanced Scientific Research
87
2
Flagship Pioneering Innovations VI, LLC.
456
2
L'OREAL, Société Anonyme
15488
1
Syngenta Participations AG
1903
1
FUJIFILM Corporation
29367
1
Michelin Recherche et Technique S.A.
2167
1
Amira Pharmaceuticals, Inc.
70
1
Epitech Group S.r.l.
22
1
Institut National de La Sante et de La Recherche Medicale (inserm)
2822
1
Institut Pasteur de Lille
174
1
Mitsubishi Gas Chemical Company, Inc.
3465
1
National University Corporation Hokkaido University
1342
1
Scent Science International Inc.
16
1
Shionogi & Co., Ltd.
854
1
The United States of America as represented by the Department of Health and Human Services
83
1
Other owners 14